Understanding how membrane nanoscale organization controls transmembrane receptors signaling activity remains a challenge. We studied interferon-g receptor (IFN-gR) signaling in fibroblasts from homozygous patients with a T168N mutation in IFNGR2. By adding a neo-N-glycan on IFN-gR2 subunit, this mutation blocks IFN-g activity by unknown mechanisms. We show that the lateral diffusion of IFN-gR2 is confined by sphingolipid/cholesterol nanodomains. In contrast, the IFN-gR2 T168N mutant diffusion is confined by distinct actin nanodomains where conformational changes required for Janus-activated tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) activation by IFN-g could not occur. Removing IFN-gR2 T168N-bound galectins restored lateral diffusion in lipid nanodomains and JAK/STAT signaling in patient cells, whereas adding galectins impaired these processes in control cells. These experiments prove the critical role of dynamic receptor interactions with actin and lipid nanodomains and reveal a new function for receptor glycosylation and galectins. Our study establishes the physiological relevance of membrane nanodomains in the control of transmembrane receptor signaling in vivo.
SUMMARY
Understanding how membrane nanoscale organization controls transmembrane receptors signaling activity remains a challenge. We studied interferon-g receptor (IFN-gR) signaling in fibroblasts from homozygous patients with a T168N mutation in IFNGR2. By adding a neo-N-glycan on IFN-gR2 subunit, this mutation blocks IFN-g activity by unknown mechanisms. We show that the lateral diffusion of IFN-gR2 is confined by sphingolipid/cholesterol nanodomains. In contrast, the IFN-gR2 T168N mutant diffusion is confined by distinct actin nanodomains where conformational changes required for Janus-activated tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) activation by IFN-g could not occur. Removing IFN-gR2 T168N-bound galectins restored lateral diffusion in lipid nanodomains and JAK/STAT signaling in patient cells, whereas adding galectins impaired these processes in control cells. These experiments prove the critical role of dynamic receptor interactions with actin and lipid nanodomains and reveal a new function for receptor glycosylation and galectins. Our study establishes the physiological relevance of membrane nanodomains in the control of transmembrane receptor signaling in vivo.
INTRODUCTION
Receptor spatiotemporal distribution and dynamics at the cell surface is an essential feature of receptor-mediated signal transduction (Kusumi et al., 2012a; Rao and Mayor, 2014) . The nanoscale organization of the plasma membrane (PM) is therefore likely to be a key factor in the control of transmembrane receptors signaling and biological activities. Over the last few years, numerous studies have addressed the molecular dynamics and nanoscale organization of the PM in the search for dynamic organizing principles commanding the compartmentalization and function of membrane proteins. Since the initial proposal of the raft concept (Simons and Ikonen, 1997) , there has been a continuing debate over the nature and the function of the physical constraints that control the spatiotemporal diffusion and bioactivity of molecules at the PM. Several nonexclusive models involving membrane domains of different nature at the nanoscale level have been proposed. The lipid raft domains are formed by the preferential association of lipids and proteins into cholesterol-and sphingolipid-dependent assemblies along with the existence of domains formed by specific protein-protein interactions in cell membranes (Lingwood and Simons, 2010) . Direct or indirect interactions with the actin-based cytoskeleton also play an important role in the lateral diffusion of membrane components (Kusumi et al., 2012a; Rao and Mayor, 2014) . Present evidence supporting the role of lipids and actin in nanoscale organization of the PM derive from pharmacological treatments, analogies with model lipid systems, and advanced imaging techniques. Although these studies have considerably increased our understanding of membrane nano-organization, the current biological paradigms leave us with several processes that are poorly understood, such as coupling across the inner and outer leaflets, the interplay between membrane nanodomains and the actin cytoskeleton, the role of these interactions in signal transduction, and their physiological significance. These questions are particularly salient in the case of transmembrane signaling receptors that, in comparison to membrane lipids and proteins, have been less studied.
To gain more mechanistic insight into these processes, we investigated the signaling characteristics of the interferon-g receptor (IFN-gR) in normal and pathological contexts. IFNs serve as a paradigm to study cytokine signal transduction through the Janus-activated tyrosine kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway (van Boxel-Dezaire and Stark, 2007) . IFN-g is a pleiotropic cytokine that regulates many cellular functions and plays a key role in innate and adaptive immunity for host defense against intracellular infections and tumor control (Stark and Darnell, 2012) . The IFN-gR is a pre-assembled heterotetramer made of two IFN-gR1 and two IFN-gR2 subunits (Blouin and Lamaze, 2013) . The JAK1 and JAK2 kinases are constitutively pre-associated with IFN-gR1 and IFN-gR2 subunits, respectively. In the canonical model of IFN-g signaling, an IFN-g dimer binds to and crosslinks the IFN-gR1 subunits, which results in receptor intracytoplasmic allosteric changes. These conformational changes lead to the trans-activation of IFNgR-bound JAK1 and JAK2 (Krause and Pestka, 2007) . JAKmediated IFN-gR1 phosphorylation allows binding and phosphorylation of cytoplasmic STAT1, which is translocated to the nucleus as a transcription factor and bind GAS (IFN-g-activated site) elements present in the promoter of some ISGs (IFN-stimulated genes), thereby controlling their transcription (Platanias, 2005) .
Deficits in IFN-g responsiveness have been associated with Mendelian susceptibility to mycobacterial diseases syndrome (MSMD) characterized by increased sensitivity to nontuberculous mycobacterial infections (Bustamante et al., 2014) . The first human mutation in IFNGR2 that is associated with MSMD was described in 1998 (Dorman and Holland, 1998) . Several children suffering from MSMD syndrome were reported to have the same homozygous T168N missense mutation in IFNGR2 (Vogt et al., 2008; Vogt et al., 2005) . The T168N mutation creates an additional consensus site for N-glycosylation in the IFN-gR2 subunit, which confers a complete IFN-gR2 deficiency due to the expression of nonfunctional IFN-gR complexes at the cell surface. B cells from these patients show no IFN-g-induced gene transcription, which results in life-threatening predisposition to mycobacterial infections.
The precise molecular mechanisms that drive and control the IFN-gR complex conformational changes induced by IFN-g that lead to JAK activation remain largely elusive. Biochemical studies based on detergent-resistant membranes suggested that lipid rafts are involved in the activation of the IFN-gR complex (Marchetti et al., 2006) . However, the role of lipid nanodomains in IFN-gR dynamics and JAK/STAT signaling has not been investigated. To address these questions, we combined fluorescence correlation spectroscopy, bioluminescence resonance energy transfer, and immunochemical experiments to investigate the molecular dynamics, conformational changes, and signaling of the activated IFN-gR in B cells and fibroblasts from control and homozygous patients with the IFN-gR2 T168N congenital disorder. Our experimental data revealed that the control by galectins of the dynamic partition of the IFN-gR between lipid nanodomains and the actin cytoskeleton is critical for JAK/STAT signaling. Excess and/or abnormal binding of galectins to the mutated IFN-gR2 T168N confines IFN-gR lateral diffusion in actin nanodomains that, in contrast to lipid nanodomains, does not allow the IFN-gR conformational changes required for JAK/STAT signaling. Galectin depletion restored lateral diffusion in lipid nanodomains and JAK/STAT signaling in patient cells whereas galectin addition impaired these two processes in control cells expressing the wild-type IFN-gR.
These results establish, therefore, the physiological relevance of lipid nanodomains in receptor dynamics and transmembrane signaling activity at the PM.
RESULTS
The IFN-gR2 T168N Gain-of-N-Glycosylation Mutation Results in Complete JAK/STAT Signaling Deficiency The IFN-gR2 N168-branched neo-N-glycan is both necessary and sufficient to block IFN-g cellular responses (Vogt et al., 2005) . To identify the molecular mechanisms by which the gain-of-glycosylation mutation leads to complete IFN-gR deficiency, we first analyzed IFN-g signaling in control human fibroblasts and B cells expressing the wild-type (WT) IFN-gR2 subunit and in patient cells expressing the IFN-gR2 T168N subunit. In control cells, IFN-g stimulation led to efficient timedependent activation, i.e., tyrosine phosphorylation of STAT1. As expected, STAT1 activation resulted in efficient STAT1 translocation to the nucleus ( Figures 1A and 1B) . In contrast, patient fibroblasts and B cells expressing the IFN-gR2 T168N subunit showed very little if any STAT1 activation. As a result, STAT1 nuclear translocation was inhibited even after prolonged IFN-g stimulation (Figures 1A and 1B and not shown) . A similar phenotype was observed in human fibroblasts deleted from either the IFN-gR1 or the IFN-gR2 subunit ( Figure 1B) . We repeated these experiments in human fibroblasts expressing the IFN-gR2 T168A and T168Q mutants that lack the threonine residue in position 168 but do not bear an additional N-glycan chain (Vogt et al., 2005) . IFN-g stimulation led to efficient STAT1 activation and nuclear translocation in the IFN-gR2 T168A and T168Q mutants indicating that the additional glycan chain on Asn168 was solely responsible for the lack of JAK/STAT activation (Figures S1A and S1B). Finally, we treated patient cells with peptide N-glycosidase F (PNGase F), a treatment that restored IFN-g responsiveness in patient fibroblasts (Vogt et al., 2005) . PNGase F digestion of the IFN-gR2 T168N patient fibroblasts restored STAT1 phosphorylation, albeit at a lower level than in wildtype cells ( Figure 1C ). The level of STAT1 activation was, however, sufficient to restore STAT1 nuclear translocation in agreement with the recovery of IFN-g biological activity in PNGase F-treated patient cells. Altogether, these results indicate that the loss of IFN-g responsiveness observed in IFNgR2 T168N patients results from the inability to activate JAK/ STAT signaling by IFN-g.
IFN-g Binding and Uptake Proceed Normally in Patient Cells
We next investigated the very first steps of IFN-gR-dependent JAK/STAT signaling that is initiated by IFN-g binding to the IFN-gR1 subunit. IFN-gR2 does not directly bind IFN-g, but the (B) Same as in (A) in SV40-transformed fibroblasts from patients with the respective genotypes. The nucleus/cytosol fluorescence ratio for pSTAT1 is quantified from the fluorescence imaging (n = 3 independent experiments). Statistical significances were determined with a one-way ANOVA with Bonferroni's multiple comparison test (***p < 0.001; ns, not significant). (C) Same as in (A) for the evaluation of the PNGase F treatment on STAT1 phosphorylation and nuclear translocation. IFN-gR2 WT or IFN-gR2 T168N SV40-transformed fibroblasts were treated by PNGase F prior to IFN-g stimulation. The nucleus/cytosol fluorescence ratio for pSTAT1 is quantified from the fluorescence imaging (n = 3). Statistical significances were determined with a one-way ANOVA with Bonferroni's multiple comparison test (***p < 0.001; ns, not significant). (D) 125 I-IFN-g uptake kinetics in SV40-transformed fibroblasts bearing IFN-gR2 WT or IFN-gR2 T168N, or deleted for IFN-gR1 or IFN-gR2. The ligand uptake was expressed as the mean ± SEM of the percentage of triplicate determinations. See also Figure S1 . I-IFN-g internalization and found a similar rate and extent of IFN-g uptake in both genotypes (Figure 1D) . We confirmed that IFN-g uptake is mediated by the IFN-gR1 subunit only, as it was only slightly decreased in cells deleted from the IFN-gR2 subunit but strongly inhibited in cells deleted from the IFN-gR1 subunit ( Figure 1D ) (Krause and Pestka, 2007) . Therefore, the inactivation of the JAK/STAT signaling pathway in IFN-gR2 T168N patient cells is likely to occur at the PM, in agreement with our published work demonstrating that IFN-g-induced JAK/STAT signaling occurs before clathrin-dependent endocytosis of IFN-gR (Marchetti et al., 2006) .
Abnormal Lateral Diffusion Dynamics of IFN-gR2 T168N at the PM To investigate the contribution of the PM in IFN-gR signaling, we monitored IFN-gR membrane lateral diffusion in living cells using spot-variation fluorescence correlation spectroscopy (svFCS). svFCS is a unique and powerful FCS-based methodology that enables to monitor protein and lipid lateral diffusion regimes at high resolution and with single molecule sensitivity in the PM of living cells (Lasserre et al., 2008) . By measuring the molecular diffusion time at various spot sizes, a diffusion time t d versus spot area can be plotted as a straight line. The slope of the diffusion plots allows to determine D eff that describes the long-range mobility of the molecule of interest, and the y intercept t 0 on the time axis that indicates whether the molecule is dynamically partitioning into nanodomains (t 0 > 0), or is trapped in a molecular meshwork (t 0 < 0) (Lenne et al., 2006) . Unconstrained free-like diffusions are characterized by t 0 = 0. We carried out svFCS analysis in parallel in COS-7 cells stably co-transfected with IFN-gR1 and IFN-gR2-eGFP WT or mutants (Figures S1C and S2A) .
At steady state, IFN-gR2 WT and IFN-gR2 T168N both displayed a diffusion mode that is typical of a dynamic partition into nanodomains/assemblies with relatively high effective diffusion coefficients (Figures 2A-2D and Table S1 for svFCS data and statistical analyses). Moreover, fluorescence recovery after photobleaching (FRAP) analysis yielded similar diffusion coefficient D and mobile fraction Mf for IFN-gR2-eGFP WT and T168N mutant (D = 0.40 ± 0.02 mm 2 3 s
À1
, Mf = 0.87 ± 0.02 for IFN-gR2-eGFP WT; D = 0.38 ± 0.07 mm 2 3 s
, Mf = 0.87 ± 0.03 for IFN-gR2-eGFP T168N). Yet, the diffusion characteristics of IFN-gR2 WT and IFN-gR2 T168N at the PM were not identical. To characterize the molecular nature of these confinements, we inhibited the cell biosynthesis of sphingolipids and cholesterol with myriocin and zaragozic acid (MZ), a treatment known to disrupt lipid-based nanodomains also known as lipid rafts (Lasserre et al., 2008) . MZ treatment severely impacted the dynamics of IFN-gR2 WT confinement at the PM, as shown by an almost null y-intercept of the diffusion plot (Figures 2A and 2B ). This result indicates that IFN-gR2 WT was dynamically localized in sphingolipid-and cholesterol-dependent lipid nanodomains. In contrast with IFNgR2 WT, the lateral confinement of IFN-gR2 T168N was not modified by MZ treatment (Figures 2C and 2D) indicating that the IFN-gR2 mutant was associated with nanodomains of a different nature.
The cortical actin cytoskeleton is proving to be an important contributor to the nanoscale organization in the PM (Gowrishankar et al., 2012; Kusumi et al., 2012b) . To assess its possible involvement in the lateral confinement of the WT and mutant IFN-gR2 subunits, we treated cells with latrunculin A (LatA) to disrupt the actin cytoskeleton by depolymerizing F-actin. While LatA had a modest effect on IFN-gR2 WT lateral confinement (Figures 2A and 2B ), it fully switched IFN-gR2 T168N diffusion to a free-like regime ( Figures 2C and 2D ). These results indicate that at steady state, IFN-gR2 T168N diffusion is exclusively confined in actin-based nanodomains and not in lipid nanodomains as found for IFN-gR2 WT diffusion. In agreement with (Marchetti et al., 2006) , we found that IFN-gR2 uptake occurred through clathrin-dependent endocytosis in COS-7 cells (Figure S2C) . Importantly, basal IFN-gR endocytosis did not interfere with FCS measurements at steady state as similar FCS data were obtained under small interfering RNA (siRNA)-mediated clathrin depletion ( Figure S2B ). Moreover, the IFN-gR2 T168A and T168Q mutants exhibited the very same lipid nanodomain partitioning as IFN-gR2 WT ( Figure S2D ), indicating that the T168 extra N-glycan is the sole responsible for the marked diffusion change.
IFN-g Binding Modulates IFN-gR2 WT but Not T168N
Mutant Lateral Dynamics at the PM We next studied the effect of IFN-g binding on IFN-gR membrane dynamics. We observed, with time, a graduated diminution of both D eff and t 0 for IFN-gR2 WT lateral diffusion, which reached a plateau after 20 min of IFN-g addition ( Figure S2E ). We analyzed IFN-gR2 membrane dynamics between the 20-50 min time frame after IFN-g addition, which corresponds to a stationary state. The FRAP analysis yielded D = 0.30 ± 0.03 mm 2 3 s
À1
, Mf = 0.89 ± 0.04, consistent with a reduced mobility, but not immobilization, of IFN-gR2 upon IFN-g binding. The FCS diffusion plot for IFN-gR2 was dramatically different from the one measured at steady state since IFN-gR2 diffusion was now trapped into a molecular meshwork as indicated by the negative y-intercept (Figures 2A and 2B ). Consistently, we observed a strong reduction of molecular mobility. The meshwork was most likely formed by actin corrals as evidenced with LatA treatment. Indeed, following the depolymerization of F-actin by LatA, IFN-gR2 membrane lateral dynamics switched to a free-like regime upon IFN-g addition (Figures 2A and 2B) . Remarkably, the integrity of lipid nanodomains, as assessed by MZ treatment, was found to be a pre-requisite for the induction of the meshwork-constrained diffusion for IFN-gR2 upon IFN-g binding (Figures 2A and 2B ). The diffusion of IFN-gR2 in the actin meshwork was independent from IFN-g-induced receptor endocytosis since it also occurred in clathrin-depleted cells ( Figure S2B ).
The lateral diffusion of IFN-gR2 T168N was markedly different from IFN-gR2 WT since it was unchanged by IFN-g stimulation as shown either by svFCS or FRAP (D = 0.34 ± 0.04 mm 2 3 s À1 ; Mf = 0.90 ± 0.04) analyses. In agreement with the lack of IFN-gR2 T168N interaction with lipid nanodomains, its lateral diffusion remained unaffected by IFN-g stimulation in MZ-treated cells (Figures 2C and 2D) . Again, this was due to the T168N extra N-glycan inasmuch as the IFN-gR2 T168A and T168Q mutants exhibited the same diffusion than the IFN-gR WT under these treatments ( Figure S2D ). Altogether, these data indicate that in contrast to the T168N mutant, IFN-gR WT responds to IFN-g stimulation by changing its membrane lateral dynamics. This distinct behavior was correlated with the dynamic localization of IFNgR WT in sphingolipid-and cholesterol-dependent lipid nanodomains prior to IFN-g stimulation whereas IFN-gR T168N was confined by actin-based nanodomains.
The T168N Mutation Impairs Early IFN-gR Conformational Changes Induced by IFN-g
The current IFN-gR activation model contends that IFN-g binding initiates allosteric changes in IFN-gR2 and IFN-gR1 cytoplasmic domains that are associated with the activation and propagation of JAK/STAT signaling (Krause and Pestka, 2007) . (B) Time intercept t 0 and effective diffusion coefficient D eff for the svFCS recorded in (A). For the present and following svFCS data, t 0 and D eff are expressed by the mean ± SD, and the statistical significance between two conditions are expressed by a probability of false alarm (PFA) with the threshold defined as follow: ns, PFA >5%; *, PFA <5%; **, PFA <1%; ***, PFA <0.1%; and ****, PFA <0.001% (see Table S1 ).
(C and D) Same as in (A) and (B), respectively, for eGFP-tagged IFN-gR2 T168N. See also Figure S2 and Table S1 .
We therefore used bioluminescence resonance energy transfer (BRET) to correlate the diffusion characteristics of the activated IFN-gR complex with the molecular rearrangements induced by IFN-g binding. BRET is a powerful biophysical technique to measure protein-protein interactions as well as ligand-induced conformational changes within proteins in living cells (Lohse et al., 2012) . We measured BRET in cells expressing a fixed amount of the IFN-gR1 subunit fused to Renilla luciferase (IFNgR1-RLuc) as the BRET donor, and increasing amounts of either IFN-gR2 WT or T168N fused to the yellow variant of eGFP as the BRET acceptor (IFN-gR2-YFP WT or T168N). These experimental conditions allowed us to build saturation curves for quantitative BRET analysis (Galé s et al., 2006; Hamdan et al., 2006; Issad et al., 2007) . Only specific interactions will give a saturated BRET signal at a certain acceptor concentration in contrast to unspecific collisions that provide linear curves. Saturation curves allow to determine the BRET max and BRET 50 values. BRET max reflects the maximum energy transfer obtained when the BRET donor is saturated by the energy acceptor whereas BRET 50 , which corresponds to relative expression of donor/acceptor at 50% of the maximal energy transfer, reflects the relative affinity between the donor and acceptor partners. The BRET 50 and BRET max values allow to discriminate between a ligand-mediated BRET modulation of a donor-acceptor couple originating from conformational changes and/or physical association/dissociation dynamics. Thus, ligand modulation of BRET max without changes in BRET 50 indicates a conformational change whereas changes in BRET 50 with or without changes in BRET max will rather reflect physical changes between the donor and acceptor couple. As shown in Figure 3A , BRET measurements between IFN-gR1-RLuc and IFN-gR2-YFP WT or T168N couple displayed hyperbolic saturation curves indicating specific BRET signals in contrast to the linear curve obtained when measuring BRET between the non-relevant IFN-gR1-RLuc and IFN-aR1-YFP couple ( Figure S3A ). At resting state, the saturation curves indicated similar relative affinities (BRET 50 ) between IFN-gR1 and IFN-gR2 WT or IFN-gR2 T168N, revealing a similar propensity of IFN-gR1 association with IFN-gR2 WT or IFN-gR2 T168N ( Figure 3B) . Likewise, the extra T168N glycan did not change the BRET max measured between IFN-gR1 and IFN-gR2 ( Figure 3B ). The BRET data therefore confirm that the IFN-gR1 and IFN-gR2 subunits are constitutively pre-assembled in the absence of IFN-g (Krause et al., 2002) . They further indicate that the additional T168N glycan on IFN-gR2 does not interfere with the basal pre-assembly process.
Stimulation of cells with IFN-g led to a rapid and significant time-dependent increase in energy transfer between IFN-gR1 and IFN-gR2 in WT cells (Figures 3C and 3D) . During the first minute, the increase in BRET max was not coupled to a change in BRET 50 in support of a rapid conformational change induced by IFN-g in the IFN-gR complex (Figures 3C-3E ). After 5 min, both BRET max and BRET 50 were significantly increased for the IFN-gR1-RLuc/IFN-gR2-YFP WT couple, suggesting a modified affinity between IFN-gR1 and IFN-gR2 with potential dynamics between receptor subunits occurring after the initial conformational change. In contrast, IFN-g led to no significant BRET max increase for the IFN-gR1/IFN-gR2 T168N couple ( Figures 3C-3E ) indicating that the T168N extra glycan impaired the IFN-gR conformational changes and inter-subunit rearrangements induced by IFN-g. We also measured BRET in IFN-gR2 T168A and T168Q mutants and found no significant difference with IFN-gR2 WT confirming the selective detrimental effect of the T168N extra glycan chain on the IFN-gR conformational changes induced by IFN-g ( Figure S3B ).
We next performed real-time kinetic studies using BRET2, which allows a better spectral separation of the donor and acceptor emission peaks than standard BRET, a prerequisite for the detection of small BRET signal variations (Bacart et al., 2008) . BRET2 measurements showed a 3-fold signal increase after 1 min of IFN-g stimulation for the IFN-gR1-RLuc8/IFN-gR2-GFP2 couple (DBRET1 = 10.44 versus DBRET2 = 31.23; Figures  3C and S3C) . At 200-ms time resolution, we measured an immediate BRET2 signal increase (t 1/2 z60 ms) upon IFN-g injection, which remained stable over the first minute of stimulation (Figure S3C ). This very rapid increase is therefore consistent with a conformational rearrangement between the IFN-gR1 and IFNgR2 chains during the first minute of IFN-g stimulation. Unless specified, extra sum-of-square F test was used to compare datasets. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. In (A) and (F), the wild-type and mutant datasets comparison by a two-tailed Mann-Whitney test was not statically different. In (B) and (G), best-fit values ± SD from the saturation curves fitted with equation Y = BRET max *(X À 1)/(BRET 50 + X À 1). See also Figure S3 .
Finally, we restricted our analysis to the IFN-gR complex changes occurring at the PM by conducting similar BRET experiments on isolated membrane preparations ( Figure S3D ). While the IFN-g-dependent BRET max signal increased with time between IFN-gR1 and IFN-gR2, as observed in living cells, on the contrary, it led to a decrease in IFN-gR2 T168N cells (Figure S3D) . In that case, the dipole/distance dependence of the IFN-g-induced BRET is modified, clearly demonstrating that the T168N mutation confers different conformational rearrangements within the IFN-gR1-IFN-gR2 complex upon IFN-g binding. It also indicates that the IFN-g-induced rearrangements occur at the PM before IFN-gR uptake since receptor endocytosis does not proceed in isolated membranes.
Impaired IFN-gR T168N Conformational Changes Result in Lack of JAK Activation
We next sought to understand how the conformational changes induced by IFN-g binding at the PM could translate into the activation of the IFN-gR complex. JAK kinases serve an essential role as the intracellular signaling effectors of the IFN-gR (Blouin and Lamaze, 2013) . Fö rster resonance energy transfer (FRET) studies have shown that JAK1 and JAK2 were required for the IFN-gR complex conformational rearrangements induced by IFN-g binding (Krause et al., 2006) . A two-step model of JAK activation was proposed where IFN-g binding triggers a first conformational change in IFN-gR subunits that lead to repositioning of the associated JAKs followed by a second conformational change mediated by the recruitment of STAT1 after JAK activation (Babon et al., 2014) .
We therefore measured the IFN-g-induced dynamics of interaction between IFN-gR2 and JAK1. At steady state, BRET saturation curves measured similar BRET 50 between JAK1 and IFN-gR2 WT or IFN-gR2 T168N, indicating a similar propensity of constitutive interaction between JAK1 and IFN-gR2 WT or T168N ( Figures 3F and 3G) . Accordingly, proteomics analysis revealed similar amounts of JAK1 and JAK2 kinases present in the IFN-gR complex in cells expressing IFN-gR2 WT or T168N (Figure 4A) . Within minutes of IFN-g binding, we measured a fast and significant increase in BRET max signal between JAK1 and IFN-gR2 WT reflecting the IFN-g-induced rearrangements within the IFN-gR signaling complex ( Figure 3H ). In contrast, BRET between JAK1 and IFN-gR2 T168N remained insensitive to IFN-g stimulation ( Figure 3H ).
We confirmed this process in IFN-gR2 WT human fibroblasts where IFN-g stimulation led to a classical time-dependent increase of JAK1 and JAK2 activation measured by tyrosine phosphorylation ( Figure 3I ). In contrast, no activation of JAK1 and JAK2 could be detected in IFN-gR2 T168N patient fibroblasts in agreement with the lack of STAT1 activation ( Figures 1A  and 1B ).
Increased Galectin Binding to IFN-gR2 T168N Contributes to Impaired Receptor Partitioning and JAK/ STAT Signaling
We next performed proteomics analysis to identify the molecular basis for the distinct confinement of IFN-gR2 T168N lateral diffusion. Mass spectrometry analysis of IFN-gR2-eGFP WT or IFNgR2-eGFP T168N immunoprecipitates revealed known IFN-gR partners ( Figure 4A ). We detected similar amounts of JAK1 and JAK2 bound to IFN-gR2 T168N and IFN-gR2 WT confirming that the defect of signaling is not due to a lack of JAK recruitment to IFN-gR2 T168N. Interestingly, we found that galectin-1 (Gal1) and galectin-3 (Gal3) were bound to IFN-gR2 T168N and IFNgR2 WT. It was confirmed by immunoprecipitation experiments that revealed a 3-fold increase binding of Gal1 and Gal3 to IFN-gR2 T168N relative to IFN-gR2 WT ( Figure 4A) .
Galectins are N-acetyl-lactosamine (LacNAc) binding lectins that participate in a broad range of biological processes (Dennis et al., 2009) . Because galectin binding is proportional to the number and branching of N-glycans per protein, the increased amount of Gal1 and Gal3 bound to IFN-gR2 T168N may be due to the additional glycan chain. We therefore examined the role of Gal1 and Gal3 concentrations on IFN-gR properties. Galectins are secreted by unconventional manner (Nabi et al., 2015) , thus silencing of endogenous galectins will deplete both cytoplasmic and extracellular galectins. Gal1 and Gal3 silencing fully restored the parameters of IFN-gR2 T168N lateral diffusion to the values of IFN-gR2 WT ( Figures 4B and 4C ). IFN-gR2 T168N diffusion became sensitive to MZ treatment indicating that Gal1 and Gal3 depletion allowed IFN-gR2 T168N to relocalize in lipid nanodomains (Figures 2A and 2B ). In agreement with the relocalization of IFN-gR2 T168N in lipid nanodomains, the switch of diffusion from nanodomains to the actin meshwork was also restored after IFN-g addition ( Figures 4B and 4C) . The depletion of Gal1 and Gal3 in patient fibroblasts expressing IFN-gR2 T168N led to increased activation of STAT1 by IFN-g indicating that the restoration of IFN-gR2 T168N dynamics in lipid nanodomains was associated with the restoration of JAK/ STAT signaling ( Figure 4D) . Conversely, the addition of exogenous Gal1 and Gal3 in Gal1-and Gal3-depleted IFN-gR2 T168N patient fibroblasts impaired STAT1 activation again. Finally, addition of galectin-binding disaccharide LacNAc, but not the control disaccharide sucrose restored the strong modification of lateral diffusion in response to IFN-g addition ( Figures  4B and 4C) . Remarkably, the t 0 and D eff for the IFN-gR2 T168N in the presence of LacNAc were indistinguishable from those observed upon siRNA-mediated Gal1 and Gal3 depletion, both prior and following IFN-g stimulation. These findings establish that galectins associated with the extracellular domain of IFNgR2 T168N are responsible for the lack of IFN-g responsiveness.
Whereas the lateral diffusion characteristics of IFN-gR2 WT were not changed after Gal1 and Gal3 depletion, the addition of recombinant Gal1 and Gal3 prevented the meshwork-constrained diffusion induced by IFN-g similarly to IFN-gR2 T168N ( Figures 5A and 5B ). This effect was blocked by preincubating the recombinant galectins with LacNAc, but not with sucrose ( Figures 5A and 5B) . Likewise, the addition of Gal1 and Gal3 prevented the IFN-g-induced increase of BRET max within the IFNgR1-RLuc/ IFN-gR2-YFP BRET couple ( Figure 5D ). Conversely, IFN-g binding led to a decrease of BRET max , consistent with a different rearrangement induced by galectins upon IFN-g stimulation. Finally, the addition of recombinant Gal3 led to a concentration-dependent decrease of STAT1 tyrosine phosphorylation in IFN-gR2 WT fibroblasts ( Figure 5C ). Altogether, these data outline that the concentration of exogenous Gal1 and Gal3 bound to IFN-gR2 is a key parameter for IFN-gR partitioning (pSTAT1) by IFN-g (20 min) in IFN-gR2 T168N human fibroblasts transfected with siRNA against Gal1 and Gal3 in presence or not of exogenous Gal1 and Gal3 (3 mg 3 ml À1 ). Mean ratio ± SEM, n = 3.
One-way ANOVA with Bonferroni's multiple comparison test was used to determine statistical significance. *p < 0.05; **p < 0.01; ns, not significant. See also Table S1 . Figure 2 for the PFA threshold significance. (C) Immunoblots and quantification of STAT1 activation (pSTAT1) by IFN-g in IFN-gR2 WT human fibroblasts after addition of increasing concentrations of exogenous Gal3 (0.5 to 10 mg 3 ml À1 ) for 20 min prior to IFN-g stimulation. Mean ratio ± SEM, n = 3. One-way ANOVA with Bonferroni's multiple comparison test was used to determine statistical significance. *p < 0.05; **p < 0.01; ns, not significant.
(legend continued on next page)
and lateral diffusion dynamics and the subsequent activation of the JAK/STAT signaling pathway by IFN-g.
Lipid Nanodomains Are Required for IFN-gR Conformational Changes Associated with JAK Kinase Activation In agreement with the lateral diffusion of IFN-gR2 WT in lipid nanodomains, MZ treatment inhibited the activation and nuclear translocation of STAT1 in normal human fibroblasts after IFN-g stimulation ( Figures 6A and 6B ). The activation and nuclear translocation of STAT1 by IFN-a were not inhibited by MZ treatment, demonstrating the specificity of this regulation (data not shown). In agreement with the weak effect of LatA on IFN-gR lateral diffusion (Figures 2A and 2B ), the activation and nuclear translocation of STAT1 by IFN-g were not affected by LatA (Figures 6A and 6B). Furthermore, BRET measurements showed that MZ treatment completely abolished the IFN-g-induced rearrangements between JAK1 and IFN-gR2 WT ( Figures 6C, S4A , and S4B). Again, LatA had no effect on JAK1 and IFN-gR2 WT rearrangements ( Figures 6C, S4C, and S4D ). In agreement with the lateral diffusion of IFN-gR2 T168N that is insensitive to IFN-g and MZ (Figures 2C and 2D) , the BRET signals measured between JAK1 and IFN-gR2 T168N were also insensitive to IFN-g and to MZ and LatA treatments (Figures S5A-S5D) . Altogether, these results demonstrate that IFN-gR partitioning and lateral diffusion within lipid nanodomains is required for the rearrangements and activation of the IFN-gR induced by IFN-g.
For cytokine receptors, a salient question is to know whether this is the JAK kinase activity that controls the receptor conformational changes or the receptor changes that control JAK activity. We performed FCS in cells treated with a selective pharmacological inhibitor of JAK kinases catalytic activity (Thompson et al., 2002) . Increasing concentrations of the JAK inhibitor led to a concomitant decrease of STAT1 tyrosine phosphorylation in human fibroblasts ( Figure 6D ) without changing IFN-gR2/JAK1 basal interaction ( Figure S6A ). Whereas, inhibition of the catalytic activity of JAK had no effect on IFN-gR2 diffusion at steady state, IFN-g addition induced again a strong reduction of t 0 and D eff for IFN-gR2 ( Figures 6E and 6F ). The t 0 offset, however, did not become negative. Nevertheless, the strong decrease of molecular mobility (D eff ) suggested that the IFN-gR2 diffusion was most likely still constrained by F-actin ( Figure 6F ).
BRET saturation curves between JAK1 and IFN-gR2 WT reached a similar plateau with or without the JAK inhibitor, confirming that the JAK activity was not required for the constitutive interaction between JAK1 and IFN-gR2 ( Figure S6B ). After IFN-g stimulation, however, changes in BRET max between JAK1 and IFN-gR2 could not be observed under JAK inhibition ( Figure 6G ) demonstrating that the JAK catalytic activity is necessary for the conformational changes occurring between JAK and the IFN-gR subunits. Most importantly, inhibition of the JAK kinases did not alter the IFN-gR1/IFN-gR2 conformational changes induced by IFN-g in intact cells because we measured a similar increase of BRET max ( Figure 6H) .
Together, these experimental data confirm the two component process established by FCS. IFN-g binding is immediately followed by a conformational change between the two IFNgR1 and IFN-gR2 subunits that occurs independently from the activity of the associated JAK1 and JAK2 kinases. This primary conformational change is required for the activation of the JAK kinases, which in turn leads to a secondary conformational change within the IFN-gR signaling complex that allows STAT activation.
DISCUSSION
We have uncovered the molecular mechanisms by which patients bearing the T168N IFN-gR2 gain-of-glycosylation mutation do not respond to IFN-g. Our findings provide direct evidence of the physiological role of sphingolipids/cholesterol nano-organization in IFN-gR transmembrane signaling and define the first in vivo example of a human congenital disorder in receptor transmembrane signaling associated with defects in lipid nanodomain dynamics.
JAK kinases are instrumental as intracellular mediators of cytokine receptors signaling. Our work precisely defined the choreography and chronology of the conformational changes that occur during JAK/STAT activation by IFN-g. IFN-g binding leads to a first IFN-gR1/IFN-gR2 subunit conformational change that is required for JAK activation. This initial change is conditioned by the presence of the IFN-gR complex in lipid nanodomains and does not require JAK catalytic activity. The resulting JAK activation leads to a second IFN-gR2/JAK1 conformational change that is required for STAT1 activation. These changes take place at the PM before IFN-gR internalization, in agreement with our finding that IFN-g signaling was independent from IFNgR endocytosis (Marchetti et al., 2006) . Allosteric changes within the receptor complex condition JAK activation as illustrated by the growth hormone receptor (Brooks et al., 2014) . Here, we further show that the IFN-g-induced conformational changes are closely integrated with the lateral partitioning of IFN-gR in lipid nanodomains. Indeed, confinement of IFN-gR T168N into actin nanodomains does not support these two conformational changes blocking thereby IFN-g signaling and biological activity in patient cells. In this context, it is interesting that a sphingolipid binding motif was identified in the transmembrane domain of the IFN-gR1 subunit (Contreras et al., 2012) . Whether this motif is involved in the selective association of the IFN-gR complex with lipid nanodomains is a possibility that will have to be tested.
The importance of the actin cytoskeleton in membrane nanoorganization has recently been outlined (Gowrishankar et al., 2012; Raghupathy et al., 2015) . Cortical actin, which is attached to the PM, can restrict the mobility of lipids and proteins and contribute to the formation and dynamics of membrane (D) Kinetics of DmBRET max values for IFN-gR1-RLuc / IFN-gR2-YFP WT interaction following IFN-g stimulation in cells preincubated for 20 min in presence of exogenous Gal1 and Gal3 (3 mg 3 ml À1 ). Mean ± SD, n = 4. Two-tailed Mann-Whitney test was used to compare non-treated versus treated datasets. *p < 0.05; ns, not significant. See also Table S1 .
nanodomains. How cortical actin controls the dynamics and the interactions of transmembrane proteins remains poorly understood and, in most cases, the molecules that bridge the receptors to actin are unknown. Latrunculin experiments revealed that at steady state, cortical actin, while contributing to IFNgR2 lateral diffusion, played nevertheless a minor role in the confinement of IFN-gR2 diffusion by membrane nanodomains. Whereas IFN-g led to a dramatic switch of IFN-gR confined lateral diffusion from lipid nanodomains to actin meshwork, the fact that JAK/STAT activation was not inhibited by latrunculin suggested nevertheless that the switch of diffusion was not required for IFN-gR activation and occurred thereafter. Finally, this study reveals the role of galectins in the regulation of IFN-gR dynamics and JAK/STAT signaling. Galectins are a 15-member family of widely expressed b-galactoside-binding mammalian lectins forming complexes that crosslink glycolipids and glycoproteins to organize a dynamic lattice that controls their compartmentalization and diffusion at the PM (Nabi et al., 2015) . Mammary tumor cells with upregulated Mgat5, the Golgi enzyme that substitutes N-glycan with poly-LacNAc, a highaffinity ligand for Gal3, show reduced EGF-R diffusion and increased interaction with actin (Lajoie et al., 2007) . The galectin lattice and the actin cytoskeleton controlled in an opposite manner the biochemical partition of the T cell receptor and the CD45 phosphatase (Chen et al., 2007) . A model for glycoprotein-galectin interactions has been proposed where N-glycan number and branching modifications at the Golgi apparatus account for the multivalency and additive effects of the branched N-glycans on galectin binding (Dennis and Brewer, 2013) . Gal1 and Gal3 depletion/replenishment experiments allowed us to directly establish the functional role of galectin multivalency in the control of receptor partitioning, conformational changes, and signaling. The presence of one single additional N-glycan branch is sufficient to drive the IFN-gR T168N complex away from lipid nanodomains and to retain it in actin nanodomains where IFN-gR activation cannot proceed. The fact that depleting or adding Gal1/Gal3 did not fully rescue or inhibit JAK/STAT signaling in T168N and WT fibroblasts, respectively, suggests that in addition to their concentration, the stoichiometry of bound galectins may also be important. It is also possible that in addition to Gal1 and Gal3, other galectins contribute to the pathogenesis of the T168N mutation. Gal1 and Gal3, which are mostly produced by immune cells, control several immune functions including pathogen recognition (Rabinovich and Toscano, 2009) . Increased synthesis of Gal3 was described in Mycobacterium leprae infection (Chung et al., 2013) . The weakened host resistance to mycobacteria observed in IFN-gR T168N patients (Vogt et al., 2005 ) may therefore result not only from excess Gal3 binding to the IFN-gR2 mutated subunit but also from a pathological increase of Gal3 synthesis.
The number of identified congenital disorders of protein N-glycosylation has dramatically increased over the last 10 years (Freeze, 2006) . Our findings emphasize the need to better understand the role of galectin interaction with glycosylated receptors in normal and pathological contexts and provide a foundation for alternative therapies to modifiers of glycosylation.
EXPERIMENTAL PROCEDURES
For plasmid, cell, antibody, and reagent information, see the Supplemental Experimental Procedures. svFCS All svFCS measurements were recorded at 37 C on a homemade confocal microscope as previously described (Billaudeau et al., 2013 ) (see also the Supplemental Experimental Procedures). Overnight, serum-starved cells were treated with ±1,000 UI 3 ml À1 human IFN-g for 30 min at 37 C prior recordings. Measurements on siRNA transfected cells were recorded 72 hr after electroporation. The autocorrelation functions (ACF) were analyzed by homemade-designed programs. The statistical comparisons between FCS diffusion plots established on a minimal of 800 ACF, were tested independently for t 0 and D eff accounting for their variances, returning a value of the probability of false alarm (PFA) (Billaudeau et al., 2013) . The values correspond to the probability that the compared values are originated from the same statistical process. All statistical results for t 0 and D eff are shown in Table S1 .
BRET Saturation Assays CHO cells were transiently transfected with BRET donor (Rluc for BRET1 or Rluc8 for BRET2) and BRET acceptor (YFP for BRET1 and GFP2 for BRET2)-encoding plasmids using Fugene 6 (Roche). The total amount of transfected DNA was maintained constant using the pcDNA3.1 (Invitrogen) empty vector. Twenty-four hours after transfection, cells were washed with PBS, detached using PBS/5 mM EDTA, resuspended in PBS, and distributed in a See also Figures S4, S5 , and S6 and Table S1 .
96-well micro-plate (Wallac, PerkinElmer). The standard BRET luciferase substrate, colenterazine-h or the RLuc8 substrate, coelenterazine 400a (Interchim) were added at a final concentration of 5 mM. Luminescence and fluorescence were measured simultaneously using the Mithras fluorescenceluminescence detector (Berthold) and/or a modified Infinite F500 (Tecan Group). Cells expressing BRET donors alone were used to determine BRET signal background. Filter sets were 485 ± 10 nm for luciferase emission, 530 ± 12.5 nm for YFP emission, 370-450 nm for RLuc8 emission, and 510-540 nm for GFP2 emission. BRET ratios were calculated as previously described (Claudinon et al., 2009 ). In saturation curves, for each time point or condition evaluated, BRET max and BRET 50 values were calculated by fitting the saturation curve with the binding equation Y = BRET max *(X À 1)/(BRET 50 + X À 1) where X = YFP/YFP 0 /RLuc corresponds to the normalized expression level and Y is the measured mBRET value (GraphPad Prism software).
For kinetic experiments, unstimulated cells mBRET max values were substracted from IFN-g-treated mBRET max values to generate the DmBRET max representation. In BRET2 kinetics, coelenterazine 400a was added before injection of the ligand. Readings were then collected at 200-ms intervals for 60 s. Ligand was injected 5 s after the beginning of the reading to allow baseline recording followed by real-time recording of the BRET changes. Net BRET signals were determined for each time point by calculating the ratio of the light emitted by GFP2 over that emitted by RLuc8. Specific ligand modulated-BRET signal was obtained by substracting the BRET ratio acquired following PBS injection. 
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